Latest Capital Raises News

ALS Limited has announced a fully underwritten A$350 million equity placement to fund major upgrades to its global laboratory network and support future growth initiatives, aiming for mid single-digit EPS accretion by FY25 pro forma.

ALS Limited reported a robust FY25 with $3 billion revenue driven by Life Sciences growth and resilient Commodities, announcing a $350 million equity raise to fund strategic expansion.

ALS Limited reported a 16% revenue increase to nearly $3 billion in FY2025, driven by acquisitions and organic growth, while underlying net profit after tax dipped slightly. The company announced a $350 million equity raise to fund expansion and sustainability initiatives.

Metro Performance Glass reported a net loss for FY25 amid market softness but outlines a clear recovery plan with leadership changes and an equity raise to strengthen its position.

Yowie Group has posted its first profitable seasonal quarter, driven by strategic cost control and product improvements, but faces ongoing capital challenges due to a significant loan default by Keybridge Capital.

Cauldron Energy Limited has announced a fully underwritten entitlement offer to raise nearly $2 million, aimed at advancing its Yanrey Uranium Project and shoring up working capital. The offer, priced at $0.006 per share, could reshape shareholder control dynamics depending on participation.

Cauldron Energy has launched a fully underwritten entitlement offer to raise nearly $2 million, aiming to advance its Yanrey Uranium Project amid growing global uranium demand and hopes for regulatory change in Western Australia.

Norwest Minerals has successfully closed a $4.85 million entitlement offer, positioning itself to advance exploration and drilling at its Bulgera gold project. The capital raise aims to unlock the potential of a 218,000-ounce gold resource.

New Age Exploration has revealed multiple high-grade gold intercepts from its maiden drilling at the Wagyu Gold Project in Western Australia, confirming a broad and open supergene mineralisation system.

OncoSil Medical has launched a $8.7 million capital raising via a Share Purchase Plan and Placement, seeking shareholder approval for options issuance and a 400:1 share consolidation.

OncoSil Medical has secured $8.7 million through a placement and share purchase plan to fund commercialization of its pancreatic cancer treatment device, aiming for positive cash flow by mid-2026. Near-completion clinical trials could soon unlock broader market access.

Jameson Resources has announced a $3.5 million equity raise to advance its Crown Mountain Hard Coking Coal Project in British Columbia, supported by a positive feasibility update and strong government backing amid geopolitical trade tensions.